Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Senseonics (NASDAQ: SENS) announced management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 11, 2026 in Snowbird, Utah.

Rhea-AI Summary

Senseonics (NASDAQ: SENS) announced management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 11, 2026 in Snowbird, Utah.

Investors seeking a meeting are advised to contact their BTIG representatives to request a meeting with Senseonics management.

Argus Jan 29 session

+2.05% close to close Open Argus

Details

News Market Reaction – SENS

On Jan 29, the first trading day after this news, SENS closed 2.05% above the previous close.

Data tracked by StockTitan Argus for the Jan 29 session.

Market Context

This announcement highlights Senseonics’ participation in a major BTIG MedTech and digital health co...

Analysis

This announcement highlights Senseonics’ participation in a major BTIG MedTech and digital health conference on February 11, 2026, extending its pattern of active investor engagement around its implantable CGM technology. Recent history features record revenue, expanded commercial partnerships, and a move to the Nasdaq Global Select Market. Investors may watch for follow-up presentations, pipeline updates, and any use of the existing $300 million shelf as key future catalysts and risk factors.

Key Figures

Conference edition: 13th Annual Conference date: February 11, 2026

Conference edition

13th Annual

BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Conference date

February 11, 2026

BTIG conference participation in Snowbird, Utah

Historical Context

5 past events · Latest: Jan 12

5 events

1. Jan 12

   Prelim revenue, update

   24h Move

   -1.5%

   Record Q4 and 2025 revenue, strong 2026 guidance and business update.

2. Jan 08

   Product integration launch

   24h Move

   +1.4%

   First commercial patients using Eversense 365 with twiist AID system.

3. Nov 10

   Conference participation

   24h Move

   +5.3%

   Participation in Stifel 2025 Healthcare Conference and investor meetings.

4. Nov 10

   Exchange transfer

   24h Move

   +5.3%

   Transfer of stock listing from NYSE American to Nasdaq Global Select Market.

5. Nov 05

   Quarterly earnings

   24h Move

   +0.6%

   Q3 2025 revenue growth, improved gross profit, and narrowed net loss.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

continuous glucose monitoring (CGM)

1 terms

continuous glucose monitoring (CGM) medical

"long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes"

A continuous glucose monitoring (CGM) system is a small wearable sensor and transmitter that measures a person’s blood sugar levels continuously and sends real‑time readings to a display or smartphone app, reducing the need for finger‑prick tests. Investors care because CGM shifts diabetes care toward ongoing device sales, subscriptions and data services; wider patient adoption, insurance coverage and better accuracy can drive steady revenue and create opportunities for new health products and analytics, similar to moving from one‑off purchases to a subscription service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GERMANTOWN, Md., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 11, 2026 in Snowbird, Utah.

To request a meeting with Senseonics, investors should contact their BTIG representatives.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems Eversense® 365 and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

Senseonics Investor Contact
Jeremy Feffer
LifeSci Advisors
investors@senseonics.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Senseonics (SENS) present at the BTIG conference in 2026?

Senseonics management will participate on February 11, 2026 at the BTIG conference. According to the company, the meeting will take place in Snowbird, Utah, as part of the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference schedule.

How can investors request a meeting with Senseonics (SENS) at the BTIG conference?

Investors should contact their BTIG representative to request a meeting with Senseonics management. According to the company, BTIG handles meeting scheduling and investor requests for the February 11, 2026 conference in Snowbird, Utah.

What topics will Senseonics (SENS) management likely cover at the BTIG conference?

Management is expected to discuss Senseonics' long-term implantable CGM systems and business updates. According to the company, the participation centers on MedTech and digital health themes relevant to their continuous glucose monitoring technology.

Where is the BTIG 13th Annual MedTech conference being held for Senseonics (SENS)?

The conference will be held in Snowbird, Utah on February 11, 2026. According to the company, Senseonics management will attend the BTIG event focused on MedTech, digital health, life science, and diagnostic tools.

Will Senseonics (SENS) provide a public webcast or investor materials for the BTIG presentation?

The announcement does not mention a public webcast or materials for the BTIG presentation. According to the company, investors should coordinate with BTIG representatives for meeting access and any available investor engagement at the February 11, 2026 event.